Why do most organizations struggle to get their innovations to market?
Scientists, Entrepreneurs, and Inventors work hard towards creating positive change through their solutions. However, these innovative solutions find it difficult to get to market successfully due to:
Lack of translational experience
Constrained research and development
Limited understanding of market demands
Issues during manufacturing and scale-up
Lack of support and trust from partners
Funding issues
Bigtec redefines partnerships
Bigtec is always looking at ‘new frontiers of technology’ and design solutions for alleviating healthcare challenges globally. We are engaged with the wider global ecosystem, working with innovators and startups in an open innovation and co-development model. This helps us collectively build products and deliver health solutions that improve social equity.
Having built our network, we understand firsthand how challenging it can be to bring game-changing innovations to market. Therefore, we strive to ensure that our partnerships succeed by:
EDGE: Our Partnership Program
Innovations get to market much more quickly if they have been nurtured right from the start. To do so, Bigtec has launched EDGE, our global program where we collaborate with MedTech startups and SMEs to accelerate the rate of product development and commercialization. This partnership could involve bridge funding for product co-development, licensing, sales, and distribution. Learn more about this program.
How we help partners get to market
The journey from being an idea to a deployed healthcare solution is long and requires a lot of external information and assistance. To help our partners in this journey, we offer them access to our expertise and comprehensive ecosystem of institutes, organizations, and public health agencies.
The support ecosystem for our partners
Provide access to our labs and our sales & distribution network
We help you tap into our extensive ecosystem of national and international partners
Work on your products with our vendor partners
Partnerships that are making a difference
Prognosys
The unique PRORAD Portable and Ultra-Portable digital x-ray machines deliver high-quality chest images combined and use Artificial Intelligence (AI) driven algorithms for automated interpreting and reporting at the Point-of-Care
Stellar
This is an Antibody detection based Rapid TB Triage test. STELLAR operates in the field of research and development of screening Tuberculosis (“TB”) immunogenic peptides derived from TB bacterial specific cell wall proteins. Serological diagnosis by estimating antibody titer against selected immunogenic peptides is carried out in lateral flow assay format and can be adapted to other formats.
Niramai
The novel screening solution called Thermalytix enables early detection of breast cancer at Point-of-Care in a privacy-aware manner through AI-based software. It uses thermal scanning and smart automated AI-enabled software to detect early signs of breast cancer in a radiation and pain-free manner
ShanMukha
India’s first indigenous CDSCO-approved, Point-of-Care test for Sickle Cell anemia detection uses High-Performance Optical Spectroscopy to differentiate between sickle disease and trait with a single drop of blood, delivering test results in just 15-20 minutes
Docturnal
Docturnal’s TimBre is a non-invasive tuberculosis screening AI-enabled tool that detects TB infection through cough sound analysis, eliminating the need for invasive procedures and potentially improving TB diagnosis and patient outcomes
XCyton Diagnostics Limited
XCyton develops panels primarily for sepsis, fever, and bacterial & viral meningitis which are currently run using hybridization and PCR. In partnership with Molbio, the panels will be converted to RT-PCR format. This will make them compatible with Molbio’s Point-of-Care devices and enable panel-based diagnosis for a multitude of diseases
Testi Technologies
Testi Technologies has developed Promilless, a saliva-based enzymatic test strip that can accurately detect blood alcohol concentration (BAC). The product range includes three different saliva test strips, which measure blood alcohol content in three limit variants: Zero, 0.2, and 0.5